ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

241–260 of 737 studies

E2 ModerateCohortPEM unclearLongitudinal

Predictors of impaired functioning among long COVID patients.

Jason, Leonard A, Dorri, Joseph A·Work (Reading, Mass.)·2023

This study followed Long COVID patients from their first two weeks of illness through about five months later to understand which early symptoms predict worse long-term outcomes. Researchers found that people who experienced problems with their autonomic nervous system (heart rate, blood pressure, temperature control) and stomach issues early on were more likely to have difficulty returning to work and family life. The same early symptoms were also linked to developing ME/CFS.

Evidence Atlas

Evidence browser

Predictors of impaired functioning among long COVID patients.

A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients.

Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome.

Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic.

Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Exercise intolerance associated with impaired oxygen extraction in patients with long COVID.

Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway.

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).

Activity measurement in pediatric chronic fatigue syndrome.

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground?

The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study.

Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study.

Improvement of Long COVID symptoms over one year.

Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome.

Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults.

Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?

ME/CFS and Post-Exertional Malaise among Patients with Long COVID.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research